Abstract
The Raf–MEK–ERK pathway couples growth factor, mitogenic and extracellular matrix signals to cell fate decisions such as growth, proliferation, migration, differentiation and survival1,2. Raf-1 is a direct effector of the Ras GTPase and is the initiating kinase in this signalling cascade. Although Raf-1 activation is well studied, little is known about how Raf-1 is inactivated. Here, we used a proteomic approach to identify molecules that may inactivate Raf-1 signalling. Protein phosphatase 5 (PP5) was identified as an inactivator that associates with Raf-1 on growth factor stimulation and selectively dephosphorylates an essential activating site, Ser 338. The PP5-mediated dephosphorylation of Ser 338 inhibited Raf-1 activity and downstream signalling to MEK, an effect that was prevented by phosphomimetic substitution of Ser 338, or by ablation of PP5 catalytic function. Furthermore, depletion of endogenous PP5 increased cellular phospho-Ser 338 levels. Our results suggest that PP5 is a physiological regulator of Raf-1 signalling pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kolch, W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nature Rev. Mol. Cell Biol. 6, 827–837 (2005).
O'Neill, E. & Kolch, W. Conferring specificity on the ubiquitous Raf/MEK signalling pathway. Br. J. Cancer 90, 283–288 (2004).
Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179–185 (1995).
Wellbrock, C., Karasarides, M. & Marais, R. The RAF proteins take centre stage. Nature Rev. Mol. Cell Biol. 5, 875–885 (2004).
Jaumot, M. & Hancock, J. F. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14–3-3 interactions. Oncogene 20, 3949–3958 (2001).
Abraham, D. et al. Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J. Biol. Chem. 275, 22300–22304 (2000).
Dhillon, A. S., Meikle, S., Yazici, Z., Eulitz, M. & Kolch, W. Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J. 21, 64–71 (2002).
Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D. & Morrison, D. K. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13, 1356–1364 (2003).
Link, A. J. et al. Direct analysis of protein complexes using mass spectrometry. Nature Biotechnol. 17, 676–682 (1999).
Wolters, D. A., Washburn, M. P. & Yates, J. R., 3rd. An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73, 5683–5690 (2001).
Chinkers, M. Protein phosphatase 5 in signal transduction. Trends Endocrinol. Metab. 12, 28–32 (2001).
Yang, J. et al. Molecular basis for TPR domain-mediated regulation of protein phosphatase 5. EMBO J. 24, 1–10 (2005).
Ali, A. et al. Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes Dev. 18, 249–254 (2004).
Xiang, X., Zang, M., Waelde, C. A., Wen, R. & Luo, Z. Phosphorylation of 338SSYY341 regulates specific interaction between Raf-1 and MEK1. J. Biol. Chem. 277, 44996–45003 (2002).
Tran, N. H. & Frost, J. A. Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition. J. Biol. Chem. 278, 11221–11226 (2003).
Chong, H., Lee, J. & Guan, K. L. Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J. 20, 3716–3727 (2001).
Diaz, B. et al. Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol. Cell Biol. 17, 4509–4516 (1997).
Chaudhary, A. et al. Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Curr. Biol. 10, 551–554 (2000).
Alavi, A., Hood, J. D., Frausto, R., Stupack, D. G. & Cheresh, D. A. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301, 94–96 (2003).
Jin, S., Zhuo, Y., Guo, W. & Field, J. PAK1-dependent phosphorylation of RAF-1 regulates its mitochondrial localization, phosphorylation of BAD, and BCL-2 association. J. Biol. Chem. 280, 24698–24705 (2005).
Morita, K. et al. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 20, 6028–6036 (2001).
Gong, C. X. et al. Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5. J. Neurochem. 88, 298–310 (2004).
Wechsler, T. et al. DNA-PKcs function regulated specifically by protein phosphatase 5. Proc. Natl Acad. Sci. USA 101, 1247–1252 (2004).
Dougherty, M. K. et al. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 17, 215–224 (2005).
Dhillon, A. S. et al. A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation. Mol. Cell Biol. 23, 1983–1993 (2003).
Acknowledgements
We thank D. Morrison, P. Cohen, M. Chinkers and X.-F. Wang for reagents and R. Honkanen for advice on PP5 siRNA. We also thank V. Cleghon for comments on the manuscript. This work was supported by Cancer Research UK, the European Union (FP6 Interaction Proteome) and the Wellcome Trust.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Figures S1, S2, S3, S4 and Methods (PDF 416 kb)
Rights and permissions
About this article
Cite this article
von Kriegsheim, A., Pitt, A., Grindlay, G. et al. Regulation of the Raf–MEK–ERK pathway by protein phosphatase 5. Nat Cell Biol 8, 1011–1016 (2006). https://doi.org/10.1038/ncb1465
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb1465
This article is cited by
-
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies
Nature Reviews Cancer (2024)
-
Truncated SCRIB isoform promotes breast cancer metastasis through HNRNP A1 mediated exon 16 skipping
Acta Pharmacologica Sinica (2023)
-
HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation
Nature Communications (2022)
-
Differential responses to kinase inhibition in FGFR2-addicted triple negative breast cancer cells: a quantitative phosphoproteomics study
Scientific Reports (2020)
-
Structure and function of the co-chaperone protein phosphatase 5 in cancer
Cell Stress and Chaperones (2020)